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Australian women’s experiences of  
the subdermal contraceptive implant:  
A qualitative perspective
Kumiyo Inoue, Marguerite Kelly, Alexandra Barratt, Deborah Bateson, Alison Rutherford, Kirsten I Black, Mary Stewart, Juliet Richters
ong-acting reversible contraceptives (LARCs), including 
the subdermal implant (etonogestrel, sold in Australia 
under the brand name Implanon), are highly effective and 
safe, and are thus recommended by health professionals as 
suitable for women of all ages.1,2 The prescription rate of the 
implant has increased steadily in Australia,3 but its use is still 
lower than in other comparable countries.1 
Approximately half of the women who commenced using 
the implant in Australia4,5 and the UK6 discontinued it within 
two years. Major reasons for discontinuation are discontent 
with bleeding patterns,7 abnormal bleeding5,8 and mood 
changes.4 However, women report a wider range of reasons for 
discontinuation that are not always captured by side-effect data 
in clinical studies.9 
This is not surprising because contraceptive research often 
uses outcome variables that may mask women’s points of 
view by categorising responses seen as clinically irrelevant as 
‘other’.10 For this reason, a qualitative approach is recommended 
to gain an accurate understanding of women’s views.9,10 A 
qualitative study11 of young women aged 16–22 years in the 
UK acknowledged the complexities involved in the decision 
to discontinue the implant. Furthermore, a recent Australian 
study identified that 40% of women changed contraceptive 
method for non-contraceptive reasons.12 Examination of clinical 
side effects alone fails to adequately engage with women’s 
actual experiences and the subtle nuances that ‘tip’ them into a 
discontinuation decision. 
An in-depth qualitative approach to understanding the 
experiences of Australian women who have used the implant 
is lacking in research to date. This article describes the lived 
experiences of 10 Australian women who have used the 
implant, some multiple times. The study illuminates women’s 
nuanced responses, and characterises their multidimensional 
and complex reasons for (dis)continuing the implant. 
Background
The number of prescriptions for contraceptive implants has 
steadily increased in Australia, but implant use is still low.
Objectives
The objectives of the study were to describe women’s nuanced 
responses, and characterise their multidimensional and 
complex reasons for (dis)continuing use of the contraceptive 
implant.
Method
A descriptive qualitative approach was used for this study. A 
larger qualitative study using in-depth, open-ended interviews, 
conducted in New South Wales between 2012 and 2013 with 
94 women aged 16–49 years who had used contraception, 
included 10 interviews containing accounts of implant use. The 
10 interviews were analysed thematically in the present study.
Results 
The three main themes analysed from the 10 interviews were 
perceived benefits, undesirable experiences and perseverance. 
Discussion
The participants were well informed about the benefits of the 
implant. Many persevered with it for a significant period of time 
before discontinuing it, despite experiencing side effects such 
as bleeding or mood changes. A decision to discontinue was 
often only made after an accumulation of multiple side effects. 
L
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Methods
A descriptive qualitative methodology 
was used for this study. We sought to 
keep as close to the data as possible and 
report in-depth, direct descriptions of the 
participants’ experiences.13 The analysis 
specific to this article was a subset of 
a data analysis (n = 10) from a larger 
qualitative study into Australian women’s 
contraceptive understandings and 
experiences (CUE study, https://research.
unsw.edu.au/projects/contraception-
understandings-and-experiences-
australian-women). Detailed information 
about methods and procedures, including 
recruitment, ethical consideration and data 
analysis/management can be found in our 
published companion paper.14 
The prepared interview prompts that 
are specific to the implant are presented 
in Box 1. These were rarely needed in 
the interviews with implant users, in 
which participants responded to general 
open-ended questions. The de-identified 
transcripts were thematically analysed 
by the first and second authors using the 
procedure reported by Braun and Clarke.15 
Three themes were saturated in this 
subset (n = 10) of data. 
The project was approved by the 
Human Research Ethics Committee 
of the University of New South Wales 
(reference HC11504).
Results
The women often used the term ‘rod’, or 
the brand name ‘Implanon’, to describe 
the implant. In this paper, we refer to 
participants who have used a subdermal 
implant at any time (n = 10) as ‘implant 
users’, and those who were using an 
implant at the time of the interview as 
‘current users’. Demographic information 
on the participants in this study is shown 
in Table 1. Of the 10 participants, two were 
still using the implant. The remaining eight 
gave reasons for discontinuation that are 
similar to those reported in the literature, 
such as bleeding and mood-related issues, 
but the interviews illuminate the complex 
interplay of multiple factors.
Women sometimes tolerated the side 
effects from the implants for many years 
before they discontinued the method. 
The eight women who had discontinued 
using the implant had done so after 
different periods of time and for various 
reasons, and were not necessarily 
dissatisfied with it overall. Indeed, some 
of these women were satisfied with the 
implant for a period of time. The three 
saturated themes discussed in this paper 
are: perceived benefits, undesirable 
experiences and perseverance. 
Perceived benefits
All of the participants interviewed were 
well informed about the benefits of 
the implant that are often referred to in 
educational material, such as the low 
cost (specified by holders of a healthcare 
concession card), convenience (no daily 
action required), long-term effectiveness 
and possibility of managing heavy bleeding. 
Quite often, the prospect of multiple 
benefits was considered to be attractive. 
I’ve just had my third Implanon taken 
out. So it’s been nine years. I think I 
got one taken out early, but yeah, nine 
years of Implanon. I just loved the 
convenience of that and the price … 
– Chloe (30s) 
The possibility of fewer or lighter periods, 
or the absence of bleeding, was viewed 
positively by participants, and they 
enjoyed the convenience of this and 
realising that they saved on the cost of 
sanitary products. However, the impact of 
the implant on bleeding was not uniform 
between participants and varied for 
individual participants with each different 
implant used. 
The recognition of benefits is not 
necessarily shared between participants 
and health practitioners. One current user 
expressed a very positive attitude towards 
the implant. She described her experience 
as ‘eye-opening’ and ‘life-changing’. 
However, she said that it was a long time 
before she encountered a doctor who 
took her history of migraines into account 
and suggested that the implant, which 
did not contain oestrogen, would be the 
best option for her. The participant spoke 
of the improvements the implant brought 
to her life and disclosed her unsatisfactory 
experiences with previous doctors 
whom she reported had prescribed the 
contraceptive pill without thoroughly 
taking her medical history into account.
Undesirable experiences
General comments such as ‘the implant 
did not agree with me’ or ‘I did not like it’ 
were often used to summarise multiple 
bodily changes that led to discontinuation 
of the contraceptive implant. For some 
participants, the implant brought 
unpleasant experiences, including painful 
insertion and removal, and changes in 
mood and bleeding patterns. Similarly 
to the results of existing studies,14,16–20 
constant or irregular bleeding was 
described as problematic and was given 
as a reason for removal of the implant by 
most of the participants who discontinued 
using it. 
All of the implant users in our study 
were aware of the absence of bleeding 
as a possible result of implant use. In line 
with the study by Darney et al,21 a lack of 
bleeding was considered by some to be a 
non-contraceptive benefit and by others to 
be ‘unnatural’ but tolerable. The nature of 
the vaginal bleeding itself was, for some 
participants, a measure of the bodily 
effects of the implant. 
I had an Implanon for three years – 
the first one was three years, got it 
changed. No dramas at all. I had very 
Box 1. Interview prompts specific to the implant
• Have you heard of the implant (or a bar inserted into your arm)? 
• Tell me anything you know about the implant.
• Could you tell me about your experience with using the implant?
• Do you think any contraceptive methods have affected your sex life? What about the implant?
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few bleeds. But always felt kind of 
bloated and a bit tired. And then maybe 
halfway through the second one … I’d 
bleed for six weeks non-stop and then 
I’d have two weeks off. And it got really 
kind of intense and very painful. And 
the consistency got really quite dark 
and really heavy, and very sort of old 
and nasty, I guess. – Mia (20s) 
The impression from our data, that 
bleeding and mood-related side 
effects are the two main triggers 
for discontinuation of the implant, is 
consistent with other studies.4,7
The participants also described a 
variety of other reactions to the implant, 
such as headaches, pain (at various sites), 
nausea, bloating, tiredness, and dramatic 
mood changes and swings. Some 
concerns were not clearly articulated in 
terms of clinical symptoms. Statements 
such as ‘I found it difficult to lose weight’, 
‘I was emotional’, ‘I was cranky’, ‘I was 
mean’, ‘I felt angry’ and ‘I was depressed’ 
were used by participants to describe 
how they felt when they were using the 
implant. 
Table 1. Demographic information of the 10 women
Pseudonym  













scheduled to do so)
Zara (40s) Anglo-Celtic Urban No children; in a 
relationship 
Implant (1) N/A
Grace (40s) Anglo-Celtic Regional Three children; in a 
live-in relationship
Implant (3) N/A
Ella (20s) Aboriginal and 
Torres Strait 
Islander 
Rural Two children; in a 
live-in relationship
Implant (3) Continuous bleeding 








chemicals are not 
good for health
Charlotte (30s) Aboriginal and 
Torres Strait 
Islander 
Regional Two children; in a 
live-in relationship
Tubal ligation; used 
implant for ‘a few’ 
years (1)
Mood changes pointed 
out by others






about 4.5 years (2)
Bleeding irregularity 
Chloe (30s) Anglo-Celtic Regional No children; in a 
live-in relationship
Hormonal IUD; used 
implant for nine 
years (3)
Bleeding problems
Ruby (30s) Anglo-Celtic Urban Four children; not 
in a relationship
Withdrawal; used 
implant for <1 year (1)
Constant bleeding 





implant for about 
six months (1)
Intermittent bleeding 
and mental health 
effects (anxiety and 
depression)




Rural No children; in a 
live-in relationship 
Contraceptive pill; 
length of time each 
implant was used is 
unknown (3)
Three different side 
effects each time 
(bleeding, extreme 
mood changes, asthma) 
*Ethnicity was disclosed by women themselves
†‘Urban’ refers to the state capital, Sydney; ‘regional’ refers to other large towns and cities; ‘rural’ refers to smaller rural towns and localities
IUD, intrauterine device
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Quite often, participants were unsure 
whether their experience resulted 
from the implant or something else. 
Hoggart et al11 found that women did not 
necessarily consider specific changes 
in their body or emotions to be directly 
connected with the implant.
Sometimes, mood swings were 
recognised by the implant users 
themselves, but not always. Charlotte 
(30s), who described the implant 
positively as an ‘easy and secure method’, 
eventually decided to stop using it 
because her mother and others pointed 
out mood changes that she had never 
recognised herself. She stated: 
I personally thought it was okay, but 
others around me thought that my 
moods had … just mood swings, you 
know, and they just thought, 'You’re 
not right' … especially my mum. 
– Charlotte (30s)
Negative attitudes towards the implant 
only came about retrospectively for one 
participant, who spoke of the pain she 
experienced when it was removed and 
her subsequent struggle with infertility. 
Another participant, who had positive 
attitudes, described not feeling entirely 
herself and having subtle concerns that 
she was unable to pinpoint, saying ‘I 
always felt something, but I did not know 
how to describe it’. 
Bleeding and emotional problems 
affected participants personally, as well as 
affecting their relationships and sex lives. 
Some participants explained that they 
‘lost [their] sex life’ because of constant 
bleeding while using the implant. They 
described a reduced desire for sex as a 
result of physical and emotional changes, 
and instability of mood. 
So I left it in for a year, and I’d say out 
of that year, I probably had one month 
of not bleeding. That was a very tough 
year ’cause I was with a partner then 
and he kept getting very, very cranky 
because I was always bleeding. Just 
always. Even if it was just a little bit. 
Sometimes it was heavy, sometimes it 
wasn’t. It just, it was just not working 
… that was awful. It didn’t make me 
feel anything – like I didn’t feel sick or 
anything – but just the whole sex life 
and the fact that I was always having 
to wear pads, and yeah, just yuck. I just 
couldn’t do anything. I… couldn’t go 
swimming. I couldn’t just enjoy myself. 
So then I had it taken out. – Ruby (30s) 
It is not clear from this extract whether 
Ruby lacked interest in sex while she 
was bleeding, or whether she and/or 
her partner assumed that sex during 
menstruation was not acceptable or 
preferable. Women’s beliefs about sexual 
intercourse during bleeding are influenced 
by complex social, physical, psychological 
and interpersonal constraints, and 
behavioural expectations.22 The literature 
suggests that bleeding can affect the 
sexual behaviour of a woman and her 
partner.23–25 It is also possible that irregular 
bleeding is easier for women to discuss 
in a medical consultation rather than any 
sexual issues associated with it. 
Perseverance
Some participants persevered with one or 
more implants, tolerating several physical 
and emotional changes. Their decision to 
discontinue the use of the implant was 
often triggered by intolerable bleeding 
or mood changes, but was often the 
culmination of many undesirable side 
effects. 
Sylvia (20s) persevered through multiple 
side effects, but reported that it was 
intermittent bleeding that eventually 
prompted her to discontinue the implant. 
As the interview progressed, she spoke 
of changes in her cycle as well as 
psychological, openly expressing her fear 
about the bodily effects of the implant. 
Sylvia claimed that she would never use 
the implant again or recommend it to 
anyone. She described the implant as:
An evil little bar sending negativity … 
a cranky little bar in my arm … the 
Implanon. Because it affected so much 
that I sort of got a bit worried about 
what it was actually doing to my body. 
– Sylvia (20s) 
Sylvia mentioned that the mental health 
issues she experienced while using the 
implant became clearer after its removal: 
It affected my head as well … I sort of 
got to the point where I couldn’t wait to 
actually get it taken out. … and then I 
found that, after I got it taken out, sort 
of a lot of things started levelling back 
out again. – Sylvia (20s) 
Ella (20s) disclosed that she was planning 
to have her third implant removed early 
because of bleeding. She continued with 
the first and second implants despite 
recognising emotional changes such as 
feeling cranky, angry and sad. Her third 
implant was inserted after a break to ‘clean’ 
her body from hormones, even though 
she was not convinced that it was suitable 
for her, given the mood changes from 
the first two. Five months of ‘constant 
bleeding’, nausea, feeling overly emotional 
and gaining weight while using her third 
implant triggered her decision to have the 
implant removed. 
One participant persisted with three 
implants before deciding that it was 
not a suitable method of contraception 
for her. Hannah reported her reasons 
for prematurely discontinuing each of 
her three implants. She recounted her 
experiences of continuous bleeding 
for six months with her first implant, 
extreme mood changes with her second 
and asthma with the third. Hannah was 
adamant that all of these experiences 
were associated with the implants and 
explained that she was able to confirm 
the differences between what was normal 
and abnormal each time the implant was 
removed. Eventually, she came to the 
conclusion that the design of the implant 
itself was the problem. 
To have it go wrong in so many different 
ways three different times is, it just 
makes you think well maybe it needs 
redesigning, rethinking. – Hannah (20s) 
In line with other studies,7,11 we found that 
a single negative experience was unlikely 
to trigger discontinuation of the implant, 
and that some women persevered with 
it despite experiencing ongoing side 
effects. Our findings address subtle 
and apparently less significant changes 
experienced by participants, some of 
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which were not even recognised by the 
women themselves. Some participants 
in our study initially reported one side 
effect or made a short statement such 
as ‘I failed with the implant’ or ‘it did not 
work for me’. However, as the interview 
progressed, or clarification was sought 
by the interviewer, they spoke of other 
changes in their body, and quite often 
more specific and detailed stories 
subsequently emerged.
Discussion 
This article reports the only study in 
Australia to date that captures qualitative 
data about users’ perception of the 
contraceptive implant, rather than simply 
outlining reasons for discontinuation. 
It provides an in-depth qualitatively 
approached understanding of the 
experiences of Australian women who 
have ever used the implant. It also 
explores the imagery women use to 
describe their experiences, which may 
be helpful for doctors seeking to offer 
information and ongoing support to 
women using this method. 
The negative aspects of the 
participants’ experiences with the implant 
were more prominent in their own 
accounts. However, some participants 
who were unhappy with their previous 
choice of contraceptive found the implant 
to be a suitable method that improved 
their lives. The accumulation of multiple 
negative side effects over time led some 
women to discontinue the implant. 
Interestingly, these participants often 
persevered with it for a significant period. 
We identified three possible contributors 
to this finding, which warrants further 
investigation. 
First, women may not have drawn 
a connection between the perceived 
changes in their body or emotions and the 
implant. Second, women were not always 
able to clearly describe the changes they 
perceived, either when they were using 
the implant or after its removal. Third, 
women could often only be ‘conclusive’ 
about their impression of the side effects 
of the implant after discontinuation.
Many of the participants in this study did 
not raise their issues with a doctor until 
they had already decided to discontinue 
the implant. Access to well-informed 
healthcare professionals, and proactive 
encouragement at the time of insertion 
about seeking advice for any unwanted 
side effects as they arise, may support 
improved satisfaction for women. Expertly 
moderated user–provider internet forums 
on topics related to the implant may also 
be useful to give women an opportunity to 
share their experiences, and for clinicians 
to be aware of issues raised by women 
using this method of contraception.
Limitations and strengths
This qualitative study does not aim to be 
representative of all women’s views on the 
contraceptive implant, but rather to capture 
themes among users who either continued 
or discontinued the method. As we did not 
specifically target women who had used 
the implant, the number of participants 
was small. There was also a possibility of 
negative recall bias among women who 
had an implant removed, and who may 
subsequently equate it with symptoms or 
other changes in their life that may or may 
not have been associated with its use.
A cohort of current users may provide 
more positive perspectives. Baumeister 
et al found that people tend to process 
negative information more thoroughly than 
positive information, and that negative 
events tend to be more memorable.26 
Overall, the negative aspects of the 
participants’ experiences with the implant 
were more prominent in their accounts, 
which may be related to there being 
only two current and eight previous 
users who recounted their experiences 
retrospectively. 
Implications for general practice
This study suggests that GPs need to 
better understand women’s perceptions 
about the implant and incorporate these 
understandings into their contraceptive 
consultations. 
The study also indicates that some 
women may persevere through 
multiple perceived side effects from the 
contraceptive implant before deciding 
to have it removed. Health professionals 
need to be aware that women will not 
necessarily volunteer information about 
side effects unless specifically asked, 
particularly if it relates to bleeding 
interfering with sexual activity. 
There are strategies that health 
professionals can use to assist women 
with troublesome bleeding associated with 
the contraceptive implant,27 and it may be 
beneficial to discuss these at initiation to 
potentially circumvent perseverance until 
the point of discontinuation. Nevertheless, 
when advising about the potential side 
effects, health practitioners should 
reassure women that the method is 
reversible, and that early removal might 
be appropriate if troublesome side effects 
persist. Further research following women 
using the implant prospectively would 
be useful in shedding further light on 
women’s experiences of this important 
LARC method to best support its informed 
choice and ongoing use.
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